Compounds > valine

valine and Arterial Occlusive Diseases

valine has been researched along with Arterial Occlusive Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, H; Sorimachi, T; Takeuchi, S; Tanaka, R1
Cui, TX; Horiuchi, M; Iwai, M; Li, JM; Li, Z; Nakagami, H1
Baron, BM; Chopp, M; Jiang, N; Zhang, RL1
Bickers, MV; Braun, DL; Johnson, MP; Markgraf, CG1
Annichino-Bizzacchi, JM; Arruda, VR; Chiaparini, LC; Costa, FF; von Zuben, PM1

Other Studies

5 other study(ies) available for valine and Arterial Occlusive Diseases

ArticleYear
Ischemic depolarization monitoring: evaluation of protein synthesis in the hippocampal CA1 after brief unilateral ischemia in a gerbil model.
    Journal of neurosurgery, 2002, Volume: 97, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Autoradiography; Blood Glucose; Brain Ischemia; Carbon Radioisotopes; Carotid Arteries; Cell Death; Disease Models, Animal; Female; Gerbillinae; Hippocampus; Male; Membrane Potentials; Neurons; Protein Biosynthesis; Valine

2002
Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.
    Circulation, 2003, Jan-07, Volume: 107, Issue:1

    Topics: Angiotensin Receptor Antagonists; Animals; Arterial Occlusive Diseases; Cell Division; Cells, Cultured; DNA; DNA-Binding Proteins; Drug Synergism; Fatty Acids, Monounsaturated; Fluvastatin; Genes, fos; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles; Valine; Valsartan

2003
Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
    Journal of the neurological sciences, 1996, Volume: 138, Issue:1-2

    Topics: Animals; Arterial Occlusive Diseases; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Valine

1996
Behavioral recovery patterns in rats receiving the NMDA receptor antagonist MDL 100,453 immediately post-stroke.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 56, Issue:3

    Topics: Animals; Arterial Occlusive Diseases; Behavior, Animal; Cerebral Arteries; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Grooming; Male; Maze Learning; Neuroprotective Agents; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors; Valine

1997
The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
    Thrombosis and haemostasis, 1997, Volume: 77, Issue:5

    Topics: Adolescent; Adult; Alanine; Arterial Occlusive Diseases; Biomarkers; Cholesterol; Cross-Sectional Studies; Female; Genotype; Homocysteine; Homozygote; Humans; Hyperlipoproteinemias; Infant, Newborn; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Thrombophlebitis; Triglycerides; Valine

1997